JP2024542592A5 - - Google Patents
Info
- Publication number
- JP2024542592A5 JP2024542592A5 JP2024531425A JP2024531425A JP2024542592A5 JP 2024542592 A5 JP2024542592 A5 JP 2024542592A5 JP 2024531425 A JP2024531425 A JP 2024531425A JP 2024531425 A JP2024531425 A JP 2024531425A JP 2024542592 A5 JP2024542592 A5 JP 2024542592A5
- Authority
- JP
- Japan
- Prior art keywords
- alkylene
- pharmaceutically acceptable
- binding group
- alkyl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163283361P | 2021-11-26 | 2021-11-26 | |
| US63/283,361 | 2021-11-26 | ||
| PCT/US2022/050952 WO2023097038A1 (en) | 2021-11-26 | 2022-11-23 | Cleavable radioligands for targeting cell surface receptors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542592A JP2024542592A (ja) | 2024-11-15 |
| JP2024542592A5 true JP2024542592A5 (https=) | 2025-11-27 |
Family
ID=86540347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531425A Pending JP2024542592A (ja) | 2021-11-26 | 2022-11-23 | 細胞表面受容体を標的とする開裂可能放射性リガンド及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12214059B2 (https=) |
| EP (1) | EP4436979A1 (https=) |
| JP (1) | JP2024542592A (https=) |
| KR (1) | KR20240121775A (https=) |
| CN (1) | CN118451091A (https=) |
| AU (1) | AU2022397307A1 (https=) |
| CA (1) | CA3238734A1 (https=) |
| CL (1) | CL2024001560A1 (https=) |
| MX (1) | MX2024005950A (https=) |
| WO (1) | WO2023097038A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018204872A2 (en) * | 2017-05-05 | 2018-11-08 | Fusion Pharmaceuticals Inc. | Igf-1r monoclonal antibodies and uses thereof |
| AU2022397307A1 (en) | 2021-11-26 | 2024-06-06 | Full-Life Technologies Uk Limited | Cleavable radioligands for targeting cell surface receptors and uses thereof |
| WO2024126687A1 (en) * | 2022-12-16 | 2024-06-20 | Silence Therapeutics Gmbh | Nucleic acids conjugated to an albumin binding moiety |
| CN121219017A (zh) * | 2023-05-31 | 2025-12-26 | 辐联科技香港有限公司 | 缀合物及其用途 |
| AU2024282578A1 (en) * | 2023-05-31 | 2025-12-04 | Full-Life Technologies Uk Limited | Radioligands for targeting cell surface receptors and uses thereof |
| TW202540073A (zh) * | 2023-11-30 | 2025-10-16 | 大陸商輻聯科技香港有限公司 | 靶向ｓｓｔｒ受體的放射性化合物及其用途 |
| CN118240015B (zh) * | 2024-03-21 | 2025-03-21 | 中国科学院近代物理研究所 | 一种针对脑胶质瘤的靶向多肽及放射性示踪剂 |
| WO2026002208A1 (zh) * | 2024-06-28 | 2026-01-02 | 思路迪生物医药(上海)有限公司 | 前列腺特异性膜抗原小分子抑制剂及其放射性核素配合物的制备及应用 |
| WO2026080432A1 (en) * | 2024-10-07 | 2026-04-16 | Beth Israel Deaconess Medical Center, Inc. | Dimeric p-selectin inhibitors and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5021556A (en) | 1987-07-22 | 1991-06-04 | Neorx Corporation | Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides |
| US5075099A (en) | 1988-05-31 | 1991-12-24 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
| US5364613A (en) | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
| US5367080A (en) | 1990-11-08 | 1994-11-22 | Sterling Winthrop Inc. | Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods |
| US5886142A (en) | 1997-05-20 | 1999-03-23 | Thomas Jefferson University | Radiolabeled thrombus imaging agents |
| CA2721183C (en) * | 2008-04-11 | 2019-07-16 | Alnylam Pharmaceuticals, Inc. | Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
| EP3609541A4 (en) * | 2017-04-05 | 2021-04-07 | Cornell University | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies |
| CA3060143A1 (en) * | 2017-05-24 | 2018-11-29 | Itm Isotopen Technologien Munchen Ag | Novel psma-binding agents and uses thereof |
| AU2022397307A1 (en) | 2021-11-26 | 2024-06-06 | Full-Life Technologies Uk Limited | Cleavable radioligands for targeting cell surface receptors and uses thereof |
-
2022
- 2022-11-23 AU AU2022397307A patent/AU2022397307A1/en active Pending
- 2022-11-23 JP JP2024531425A patent/JP2024542592A/ja active Pending
- 2022-11-23 KR KR1020247021297A patent/KR20240121775A/ko active Pending
- 2022-11-23 EP EP22899414.1A patent/EP4436979A1/en active Pending
- 2022-11-23 CA CA3238734A patent/CA3238734A1/en active Pending
- 2022-11-23 WO PCT/US2022/050952 patent/WO2023097038A1/en not_active Ceased
- 2022-11-23 CN CN202280078538.7A patent/CN118451091A/zh active Pending
- 2022-11-23 MX MX2024005950A patent/MX2024005950A/es unknown
-
2024
- 2024-03-13 US US18/604,400 patent/US12214059B2/en active Active
- 2024-05-23 CL CL2024001560A patent/CL2024001560A1/es unknown
- 2024-12-03 US US18/967,265 patent/US20250099632A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024542592A5 (https=) | ||
| CA2526556C (en) | Stable radiopharmaceutical compositions and methods for their preparation | |
| US20250099632A1 (en) | Cleavable radioligands for targeting cell surface receptors and uses thereof | |
| JP2008266342A (ja) | 部位特異的ターゲッティング用の放射性標識ペプチド組成物 | |
| CN108290924A (zh) | 肽硫脲衍生物、含有其的放射性同位素标记化合物、和含有该化合物作为活性成分的用于治疗或诊断前列腺癌的药物组合物 | |
| JP2025506705A5 (https=) | ||
| JP7838149B2 (ja) | 癌のイメージングおよび治療のための修飾されたｇｒｐｒアンタゴニストペプチド | |
| JP5557425B2 (ja) | 改良ｎ４キレーターコンジュゲート | |
| IL305134A (en) | Dual mode radio and medical tracker | |
| US20120178906A1 (en) | Chelation of metals to thiol groups using in situ reduction of disulfide-containing compounds by phosphines | |
| EP4631959A2 (en) | Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy | |
| US20260027244A1 (en) | Silicon-based fluoride acceptor groups for radiopharmaceuticals | |
| JP2024115570A (ja) | 放射性核種標識薬剤 | |
| Floresta et al. | RSC Medicinal Chemistry | |
| TW202540073A (zh) | 靶向ｓｓｔｒ受體的放射性化合物及其用途 | |
| WO2025162868A1 (en) | Compounds comprising a silicon-based fluoride acceptor group useful as radiopharmceutical compounds | |
| HK40077105B (zh) | 具有方酸连接的标记前体 |